Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor.

Kucharik, Alison H; Curkovic, Nina B; Chavez, Julio C; Tsai, Kenneth Y; Brohl, Andrew S; Grichnik, James M

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor.

Kucharik, Alison H; Curkovic, Nina B; Chavez, Julio C; Tsai, Kenneth Y; Brohl, Andrew S; Grichnik, James M.

Afiliación

Kucharik AH; Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida.
Curkovic NB; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Chavez JC; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Tsai KY; Department of Pathology, Division of Dermatopathology, Moffitt Cancer Center, Tampa, Florida.
Brohl AS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
Grichnik JM; Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida.

JAAD Case Rep ; 51: 17-21, 2024 Sep.

Article en En | MEDLINE | ID: mdl-39345278

Palabras clave

BTKi; Bruton's tyrosine kinase inhibitor; CCV; angiosarcoma; cutaneous collagenous vasculopathy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2024 Tipo del documento: Article